Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(14)
DRUG(4)
Tamoxifen
2 trials
phase_2
university-of-california-san-francisco
Alpelisib
2 trials
phase_1
pamela-munster
Pembrolizumab
2 trials
phase_2
university-of-california-san-francisco
Carboplatin
2 trials
phase_1
pamela-munster
Vorinostat
2 trials
phase_2
university-of-california-san-francisco
BMN-673
1 trial
phase_1
pamela-munster
Cisplatin
1 trial
phase_1
pamela-munster
Irinotecan
1 trial
phase_1
pamela-munster

+5 more interventions

13 unique interventions2 categories

Analytics

Trial Phases

Phase 16
Phase 22

Trial Status

Completed2
Terminated5
Other1

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT04190056Phase 2Terminated
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
PrincipalinvestigatorStart date: 2021-03-11
NCT03318445Phase 1Completed
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
Solid Tumor, Unspecified, Adult
PrincipalinvestigatorStart date: 2018-01-12
NCT02620839Phase 1Terminated
Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies
Solid Tumors
PrincipalinvestigatorStart date: 2016-12-01
NCT02508441Phase 1Terminated
Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Advanced Unresectable Solid Tumors
PrincipalinvestigatorStart date: 2015-12-08
NCT02395627Phase 2Terminated
Reversing Therapy Resistance With Epigenetic-Immune Modification
Breast Neoplasms
PrincipalinvestigatorStart date: 2015-05-04
NCT02358200Phase 1Terminated
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
BRCA-mutated Solid TumorTriple Negative Metastatic Breast Cancer
PrincipalinvestigatorStart date: 2015-02-23
NCT01543763Phase 1Completed
Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
Metastatic Solid Tumors
PrincipalinvestigatorStart date: 2012-06-25
NCT05472220Phase 1Withdrawn
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
HPV-Related Squamous Cell CarcinomaHuman Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Squamous Cell Carcinoma+5 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmSolid Tumors
Similarity Score5%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Solid TumorsTriple Negative Metastatic Breast Cancer
Similarity Score4%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmLocally Advanced Malignant Solid Neoplasm
Similarity Score4%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmLocally Advanced Malignant Solid Neoplasm

Worked with same sponsors:

Merck Sharp & Dohme LLCNovartis+2 more
Similarity Score4%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Solid TumorsMetastatic Malignant Solid Neoplasm
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score2%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score2%

Arun Rajan, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score2%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score2%

XiaoFeng Shen, MD

Nanjing Medical University

Related
32 trials

Shared therapeutic areas:

Breast Neoplasms
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT04190056Phase 2PrincipalInvestigator

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
Terminated
NCT03318445Phase 1PrincipalInvestigator

Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

Solid Tumor, Unspecified, Adult
Completed
NCT02620839Phase 1PrincipalInvestigator

Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies

Solid Tumors
Terminated
NCT02508441Phase 1PrincipalInvestigator

Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors

Advanced Unresectable Solid Tumors
Terminated
NCT02395627Phase 2PrincipalInvestigator

Reversing Therapy Resistance With Epigenetic-Immune Modification

Breast Neoplasms
Terminated
NCT02358200Phase 1PrincipalInvestigator

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

BRCA-mutated Solid TumorTriple Negative Metastatic Breast Cancer
Terminated
NCT01543763Phase 1PrincipalInvestigator

Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

Metastatic Solid Tumors
Completed
NCT05472220Phase 1PrincipalInvestigator

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

HPV-Related Squamous Cell CarcinomaHuman Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Squamous Cell Carcinoma+5 more
Withdrawn

All 8 trials loaded